It hardly has ALL the features of the X2! LOL
They’re just adding Bluetooth connectivity and the ability to remote update.
Tandem is still alone in it’s superior Control-IQ pump automation, Dexcom integration, smaller form factor, durable metal construction vs Medtronic’s plastic casing, modern touch-screen interface, rechargeable battery, and it’s micro-divery technology that continues to set them apart in adverse events related to medical device reports.
Johnson & Johnson, a MAJOR money-making corporation with it’s hand in lots of cookie jars, owned Animas. It choose to leave the pump market simply because it wasn’t profitable enough, despite making a great pump system with lots of fans. Metronic is similarly profitable with it’s hands in lots of other cookie jars, and seriously “screwed the pooch”, so to say, with the disappointing 670G system that left so many unhappy customers flocking to Tandem instead… that I would argue that Medtronic is actually the more fiscally irresponsible choice at the moment. I wouldn’t be surprised in the least if Medtronic makes a similar corporate decision, just as Johnson & Johnson, to abandon their sinking pump market ship. Their recent decision to share technology parents with Tandem is about the only thing keeping them afloat, in my personal opinion. It’s the only reason they’ve been able to similarly tout remote updates and other features. We’ve yet to see what benefits Tandem gained in that agreement, but I suspect it will have something to do with reservoir design in their upcoming T:sport patch pump.